Evidence map›Paper›PMID 36829239›Full record

Observational studyCritical care (London, England)2023

Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest.

Helena Levin, Anna Lybeck, Attila Frigyesi, Isabelle Arctaedius, Bergthóra Thorgeirsdóttir, Martin Annborn, Marion Moseby-Knappe, Niklas Nielsen, Tobias Cronberg, Nicholas J Ashton and 4 more

Abstract readObservational Study
In one paragraph

Observational study in Critical care (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Observational
  9. [Neurological prognosis after cardiac arrest and resuscitation].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2026
    Review
  10. Article
  11. Combining plasma p-tauAlzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  12. Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Review
  19. Article
  20. Biomarkers in Cardiac Arrest: A Narrative Review.Therapeutic advances in pulmonary and critical care medicine
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Helena LevinAnesthesia & Intensive Care, Department of Clinical Sciences, Lund University, Lund, Sweden. helena.levin@med.lu.se.
Anna LybeckAnesthesia & Intensive Care, Department of Clinical Sciences, Skane University Hospital, Lund University, Lund, Sweden.
Attila FrigyesiAnesthesia & Intensive Care, Department of Clinical Sciences, Skane University Hospital, Lund University, Lund, Sweden.
Isabelle ArctaediusAnesthesia & Intensive Care, Department of Clinical Sciences, Skane University Hospital, Lund University, Lund, Sweden.
Bergthóra ThorgeirsdóttirAnesthesia & Intensive Care, Department of Clinical Sciences, Skane University Hospital, Lund University, Malmö, Sweden.
Martin AnnbornAnesthesia & Intensive Care, Department of Clinical Sciences, Helsingborg Hospital, Lund University, Helsingborg, Sweden.
Marion Moseby-KnappeNeurology, Department of Clinical Sciences Lund, Skane University Hospital, Lund University, Lund, Sweden.
Niklas NielsenAnesthesia & Intensive Care, Department of Clinical Sciences, Helsingborg Hospital, Lund University, Helsingborg, Sweden.
Tobias CronbergNeurology, Department of Clinical Sciences Lund, Skane University Hospital, Lund University, Lund, Sweden.
Nicholas J AshtonInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Hans FribergAnesthesia & Intensive Care, Department of Clinical Sciences, Skane University Hospital, Lund University, Malmö, Sweden.
Niklas Mattsson-CarlgrenClinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have reported high prognostic accuracy of circulating neurofilament light (NfL) at 24-72 h after out-of-hospital cardiac arrest (OHCA), but performance at earlier time points and after in-hospital cardiac arrest (IHCA) is less investigated. We aimed to assess plasma NfL during the first 48 h after OHCA and IHCA to predict long-term outcomes.

methodsObservational multicentre cohort study in adults admitted to intensive care after cardiac arrest. NfL was retrospectively analysed in plasma collected on admission to intensive care, 12 and 48 h after cardiac arrest. The outcome was assessed at two to six months using the Cerebral Performance Category (CPC) scale, where CPC 1-2 was considered a good outcome and CPC 3-5 a poor outcome. Predictive performance was measured with the area under the receiver operating characteristic curve (AUROC).

resultsOf 428 patients, 328 (77%) suffered OHCA and 100 (23%) IHCA. Poor outcome was found in 68% of OHCA and 55% of IHCA patients. The overall prognostic performance of NfL was excellent at 12 and 48 h after OHCA, with AUROCs of 0.93 and 0.97, respectively. The predictive ability was lower after IHCA than OHCA at 12 and 48 h, with AUROCs of 0.81 and 0.86 (p ≤ 0.03). AUROCs on admission were 0.77 and 0.67 after OHCA and IHCA, respectively. At 12 and 48 h after OHCA, high NfL levels predicted poor outcome at 95% specificity with 70 and 89% sensitivity, while low NfL levels predicted good outcome at 95% sensitivity with 71 and 74% specificity and negative predictive values of 86 and 88%.

conclusionsThe prognostic accuracy of NfL for predicting good and poor outcomes is excellent as early as 12 h after OHCA. NfL is less reliable for the prediction of outcome after IHCA.

Indexed as

Cardiopulmonary ResuscitationOut-of-Hospital Cardiac ArrestCohort StudiesHumansIntermediate FilamentsPrognosisRetrospective StudiesBiomarkerIn-hospital cardiac arrest (IHCA)Neurofilament light (NfL)Out-of-hospital cardiac arrest (OHCA)Prognostication

Identifiers

PMID36829239
PMCPMC9960417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.